Counselors in Furlong, PA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Jennifer Cunnane, MA, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 3503 York Rd Ste 7, Furlong, PA 18925 Phone: 215-317-1100 |
Melissa Maguire, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2325 Heritage Center Dr Ste 401, Furlong, PA 18925 Phone: 215-607-7444 |
 Edward Haaz, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1878 Sugar Bottom Rd, Furlong, PA 18925 Phone: 215-345-7838 |
News Archive
USAID, NASA, NIKE and State Department partner to address humanity's sustainability challenges
The U.S. Agency for International Development (USAID), NASA, the U.S. Department of State, and NIKE, Inc. have partnered on a unique initiative called LAUNCH. The idea behind LAUNCH is to identify, showcase and support innovative approaches to humanity's sustainability challenges through a series of forums, each focused on a specific sustainability challenge. The second event in the LAUNCH series, LAUNCH: Health, will focus specifically on health issues related to the first 20 years of life.
Scientists discover genetic pathway responsible for brain development
Scientists at A*STAR's Institute of Medical Biology and Institute of Molecular and Cellular Biology have identified a genetic pathway that accounts for the extraordinary size of the human brain.
British Asian cancer patients are not being met because of a lack of consideration for cultural differences
The study, carried out in Leicester, looked at the information preferences of British Asian patients – the majority of which were first generation and spoke English as well as their native language. It found that over half of English-speaking Asian patients would prefer to discuss their cancer and read health leaflets in their mother tongue.
Takeda receives FDA approval for VELCADE sNDA to treat MM
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE (bortezomib) for Injection, which updates the label to include additional long-term overall survival (OS) data from the VISTA trial.
New collaborative project to identify methods of effective working for all care homes
Improving the delivery of existing NHS services to care homes is the focus of a new collaborative project led by researchers at the University of Hertfordshire and funded by the National Institute for Health Research Health Services and Delivery Research Programme.
› Verified 8 days ago
Psychologists
Dentists
Counselors
Pharmacists
Occupational Therapists